Arrive is a group of passionate experts from diverse fields and backgrounds. Our leadership includes Anuj Gaggar (CEO), Andrew Brack (Head of Biology), and Evan Szu (COO).
We work with a network of key advisors with insights from present and past work at leading drug development organizations like Jennifer King (Intellia) Eric Suba (Kaiser), Andrew Dahlem (Eli Lilly), Marc Berger (Pfizer), Stephen Eck (Macrogenics), Joe Nolan (Jaguar Gene Therapy) and others.
Our partners include Roche, FDA, EDB Singapore, Singapore General Hospital, and others.
Arrive Head of Ageing Andrew Brack speaks at National Academy of Medicine meeting on Healthy Longevity.
Arrive Head of Aging Andrew Brack will speak at American Aging Association.
Evan Szu speaks at the Singapore Academy of Sciences.
Arrive is working with the FDA to establish standards for A.I. algorithms in pathology. Read the HTT pilot study paper.
